Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 29 | 2022 | 2450 | 1.340 |
Why?
|
| Respiration | 19 | 2013 | 465 | 1.270 |
Why?
|
| Movement | 18 | 2011 | 562 | 0.720 |
Why?
|
| Radiotherapy, Computer-Assisted | 7 | 2010 | 127 | 0.660 |
Why?
|
| Brachytherapy | 6 | 2023 | 1005 | 0.650 |
Why?
|
| Respiratory Mechanics | 6 | 2007 | 175 | 0.590 |
Why?
|
| Radiotherapy, Conformal | 8 | 2008 | 898 | 0.440 |
Why?
|
| Motion | 7 | 2022 | 200 | 0.430 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2020 | 7784 | 0.430 |
Why?
|
| Diaphragm | 3 | 2005 | 187 | 0.430 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2008 | 908 | 0.370 |
Why?
|
| Algorithms | 10 | 2011 | 3900 | 0.360 |
Why?
|
| Radiotherapy, Image-Guided | 3 | 2021 | 340 | 0.330 |
Why?
|
| Genital Neoplasms, Female | 3 | 2022 | 794 | 0.330 |
Why?
|
| Radiographic Image Enhancement | 4 | 2008 | 410 | 0.310 |
Why?
|
| Lung Neoplasms | 20 | 2011 | 12028 | 0.310 |
Why?
|
| Radiometry | 8 | 2022 | 1018 | 0.310 |
Why?
|
| Computer Simulation | 7 | 2008 | 1570 | 0.290 |
Why?
|
| Thoracic Neoplasms | 2 | 2008 | 352 | 0.280 |
Why?
|
| Radiotherapy, Intensity-Modulated | 7 | 2019 | 2161 | 0.260 |
Why?
|
| Artifacts | 8 | 2011 | 536 | 0.250 |
Why?
|
| Particle Accelerators | 7 | 2022 | 362 | 0.240 |
Why?
|
| Proton Therapy | 3 | 2022 | 1635 | 0.240 |
Why?
|
| Health Care Costs | 2 | 2019 | 699 | 0.230 |
Why?
|
| Phantoms, Imaging | 11 | 2021 | 1330 | 0.230 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2020 | 1903 | 0.220 |
Why?
|
| Models, Theoretical | 3 | 2020 | 798 | 0.220 |
Why?
|
| Radiotherapy Dosage | 11 | 2022 | 4001 | 0.220 |
Why?
|
| Vaginal Neoplasms | 1 | 2023 | 152 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 7894 | 0.200 |
Why?
|
| Health Resources | 2 | 2019 | 170 | 0.190 |
Why?
|
| Radiosurgery | 3 | 2020 | 1383 | 0.180 |
Why?
|
| Colon, Sigmoid | 1 | 2020 | 42 | 0.170 |
Why?
|
| Monitoring, Physiologic | 2 | 2011 | 522 | 0.170 |
Why?
|
| Synchrotrons | 2 | 2010 | 35 | 0.170 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2007 | 382 | 0.170 |
Why?
|
| Tumor Burden | 6 | 2016 | 2033 | 0.170 |
Why?
|
| Biofeedback, Psychology | 3 | 2007 | 50 | 0.160 |
Why?
|
| Health Facilities | 1 | 2019 | 75 | 0.160 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 142 | 0.160 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2011 | 210 | 0.150 |
Why?
|
| Reproducibility of Results | 10 | 2023 | 6192 | 0.150 |
Why?
|
| Contrast Media | 2 | 2021 | 1499 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2011 | 5569 | 0.140 |
Why?
|
| Immobilization | 2 | 2020 | 91 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2021 | 596 | 0.130 |
Why?
|
| Time Factors | 13 | 2020 | 13021 | 0.130 |
Why?
|
| Feasibility Studies | 6 | 2023 | 2363 | 0.130 |
Why?
|
| Subtraction Technique | 2 | 2008 | 143 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2020 | 1689 | 0.120 |
Why?
|
| Quality Control | 4 | 2006 | 461 | 0.120 |
Why?
|
| Models, Biological | 6 | 2009 | 3194 | 0.120 |
Why?
|
| Wireless Technology | 1 | 2013 | 17 | 0.110 |
Why?
|
| Fluoroscopy | 2 | 2005 | 223 | 0.110 |
Why?
|
| Infrared Rays | 1 | 2013 | 62 | 0.110 |
Why?
|
| Humans | 43 | 2023 | 270744 | 0.110 |
Why?
|
| Feedback, Sensory | 1 | 2011 | 21 | 0.090 |
Why?
|
| Inhalation | 1 | 2011 | 43 | 0.090 |
Why?
|
| Software | 5 | 2008 | 1356 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 1387 | 0.080 |
Why?
|
| Workflow | 2 | 2020 | 279 | 0.080 |
Why?
|
| Retrospective Studies | 10 | 2022 | 39827 | 0.070 |
Why?
|
| Organs at Risk | 2 | 2020 | 559 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 297 | 0.070 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 294 | 0.070 |
Why?
|
| Audiovisual Aids | 1 | 2006 | 40 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 4140 | 0.060 |
Why?
|
| Protons | 1 | 2008 | 482 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2007 | 5171 | 0.050 |
Why?
|
| Female | 13 | 2023 | 148945 | 0.050 |
Why?
|
| Equipment Design | 2 | 2008 | 1208 | 0.050 |
Why?
|
| Thorax | 1 | 2004 | 232 | 0.050 |
Why?
|
| Thermography | 1 | 2003 | 57 | 0.050 |
Why?
|
| Lung | 3 | 2011 | 3300 | 0.050 |
Why?
|
| Sample Size | 1 | 2003 | 213 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 2057 | 0.050 |
Why?
|
| Cell Survival | 1 | 2008 | 3063 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 2196 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2008 | 1656 | 0.050 |
Why?
|
| Patient Education as Topic | 2 | 2005 | 745 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 101 | 0.050 |
Why?
|
| Radiation Oncology | 1 | 2006 | 558 | 0.050 |
Why?
|
| Magnetic Fields | 1 | 2021 | 33 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2023 | 339 | 0.050 |
Why?
|
| Teaching | 1 | 2003 | 251 | 0.050 |
Why?
|
| Radiotherapy Setup Errors | 1 | 2020 | 85 | 0.040 |
Why?
|
| Cost Control | 1 | 2020 | 45 | 0.040 |
Why?
|
| Cobalt | 1 | 2020 | 57 | 0.040 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2021 | 303 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 587 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2020 | 106 | 0.040 |
Why?
|
| Exhalation | 2 | 2011 | 61 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 251 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 47 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 50 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 67 | 0.040 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 311 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 31006 | 0.040 |
Why?
|
| Health Personnel | 1 | 2019 | 651 | 0.030 |
Why?
|
| Medicare | 1 | 2019 | 926 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 13414 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2019 | 2271 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 1571 | 0.030 |
Why?
|
| Radiation Protection | 2 | 2005 | 204 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 2319 | 0.030 |
Why?
|
| Esophageal Stenosis | 1 | 2011 | 91 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2011 | 97 | 0.020 |
Why?
|
| Esophagitis | 1 | 2011 | 210 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 1 | 2011 | 175 | 0.020 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2010 | 51 | 0.020 |
Why?
|
| Radiation Pneumonitis | 1 | 2011 | 313 | 0.020 |
Why?
|
| Middle Aged | 5 | 2020 | 90334 | 0.020 |
Why?
|
| Patient Positioning | 1 | 2011 | 196 | 0.020 |
Why?
|
| Individuality | 1 | 2009 | 57 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 73375 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 2238 | 0.020 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2010 | 231 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 4048 | 0.020 |
Why?
|
| Adult | 4 | 2020 | 81975 | 0.020 |
Why?
|
| Uncertainty | 1 | 2010 | 326 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2005 | 1185 | 0.020 |
Why?
|
| Computers | 1 | 2008 | 132 | 0.020 |
Why?
|
| Neoplasms | 2 | 2006 | 15919 | 0.020 |
Why?
|
| Male | 6 | 2020 | 128374 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 769 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2011 | 907 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 267 | 0.020 |
Why?
|
| Computer Systems | 1 | 2006 | 113 | 0.020 |
Why?
|
| Reaction Time | 1 | 2006 | 238 | 0.020 |
Why?
|
| Deceleration | 1 | 2005 | 1 | 0.020 |
Why?
|
| Friction | 1 | 2005 | 3 | 0.020 |
Why?
|
| Calibration | 1 | 2006 | 347 | 0.020 |
Why?
|
| Statistical Distributions | 1 | 2005 | 7 | 0.020 |
Why?
|
| Gravitation | 1 | 2005 | 27 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2005 | 59 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2011 | 14012 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 360 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 2011 | 1470 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 751 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2008 | 1042 | 0.010 |
Why?
|
| Periodicity | 1 | 2003 | 72 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2003 | 121 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 477 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2003 | 271 | 0.010 |
Why?
|
| United States | 1 | 2019 | 15853 | 0.010 |
Why?
|
| X-Rays | 1 | 2001 | 151 | 0.010 |
Why?
|
| Texas | 1 | 2011 | 6447 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 5339 | 0.010 |
Why?
|
| DNA Repair | 1 | 2008 | 1910 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2008 | 1465 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 16205 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 1986 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12526 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2004 | 1857 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 1195 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 15210 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 10385 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 33733 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 62045 | 0.000 |
Why?
|